Frontiers in neurology · 2024
Transcranial photobiomodulation in children aged 2-6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology.
Fradkin et al.
Photobiomodulation
- Journal
- Frontiers in neurology
- Year
- 2024
- Publication type
- Journal Article